DIRMC

In the analysis interface, you can clearly see the specific target of each type of immunotherapy. The target with a red background indicates that the target has an approved immunotherapy, and the yellow background indicates that the drug for the target is currently in the clinical research stage. If you want to know the current research status of a specific target, which drugs are approved, and what diseases are these drugs designed for, you can learn more by clicking on the specific target.

If you want to predict the binding affinity of both MHC (including, MHC I and MHC II) and peptide, and TCR and peptide, you can choose different methods to predict the relevant results by selecting the option of MHC & peptide or TCR & peptide in the "Predict you want" box below.